Matches in Nanopublications for { ?s ?p "[In the first patients with severe combined immunodeficiency due to adenosine deaminase deficiency treated with peripheral blood lymphocytes, transduced T cells have been shown to persist for over 10 years, expressing transgenic adenosine deaminase, but the therapeutic effect of gene therapy remained difficult to assess because of the concomitant treatment with bovine adenosine deaminase conjugated to polyethylene-glycol (PEG-ADA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[In the first patients with severe combined immunodeficiency due to adenosine deaminase deficiency treated with peripheral blood lymphocytes, transduced T cells have been shown to persist for over 10 years, expressing transgenic adenosine deaminase, but the therapeutic effect of gene therapy remained difficult to assess because of the concomitant treatment with bovine adenosine deaminase conjugated to polyethylene-glycol (PEG-ADA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP936143.RArv1RMHoyLq4sbANFWkIFqG9AHRaHdSyw-lAYURftdDE130_assertion description "[In the first patients with severe combined immunodeficiency due to adenosine deaminase deficiency treated with peripheral blood lymphocytes, transduced T cells have been shown to persist for over 10 years, expressing transgenic adenosine deaminase, but the therapeutic effect of gene therapy remained difficult to assess because of the concomitant treatment with bovine adenosine deaminase conjugated to polyethylene-glycol (PEG-ADA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936143.RArv1RMHoyLq4sbANFWkIFqG9AHRaHdSyw-lAYURftdDE130_provenance.
- NP222703.RASvEMD2lGkV_kFcnmR6_2F0ZWfgngFq4JQpBeXNHJAYo130_assertion description "[In the first patients with severe combined immunodeficiency due to adenosine deaminase deficiency treated with peripheral blood lymphocytes, transduced T cells have been shown to persist for over 10 years, expressing transgenic adenosine deaminase, but the therapeutic effect of gene therapy remained difficult to assess because of the concomitant treatment with bovine adenosine deaminase conjugated to polyethylene-glycol (PEG-ADA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222703.RASvEMD2lGkV_kFcnmR6_2F0ZWfgngFq4JQpBeXNHJAYo130_provenance.
- NP420285.RAW1oImnWUo42rId6Lmc6LKPS72pTZmNALTu8DaTT5UWc130_assertion description "[In the first patients with severe combined immunodeficiency due to adenosine deaminase deficiency treated with peripheral blood lymphocytes, transduced T cells have been shown to persist for over 10 years, expressing transgenic adenosine deaminase, but the therapeutic effect of gene therapy remained difficult to assess because of the concomitant treatment with bovine adenosine deaminase conjugated to polyethylene-glycol (PEG-ADA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420285.RAW1oImnWUo42rId6Lmc6LKPS72pTZmNALTu8DaTT5UWc130_provenance.
- NP420286.RASCs5vsceB1a0DR-SuCJkUMVsqOHQ3VmH7uNEqH3vhqw130_assertion description "[In the first patients with severe combined immunodeficiency due to adenosine deaminase deficiency treated with peripheral blood lymphocytes, transduced T cells have been shown to persist for over 10 years, expressing transgenic adenosine deaminase, but the therapeutic effect of gene therapy remained difficult to assess because of the concomitant treatment with bovine adenosine deaminase conjugated to polyethylene-glycol (PEG-ADA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420286.RASCs5vsceB1a0DR-SuCJkUMVsqOHQ3VmH7uNEqH3vhqw130_provenance.
- NP605719.RAEBrtS6W5-ZWvnZqF_Ey2QLXL9eg0yBczmyYLYKkPlHo130_assertion description "[In the first patients with severe combined immunodeficiency due to adenosine deaminase deficiency treated with peripheral blood lymphocytes, transduced T cells have been shown to persist for over 10 years, expressing transgenic adenosine deaminase, but the therapeutic effect of gene therapy remained difficult to assess because of the concomitant treatment with bovine adenosine deaminase conjugated to polyethylene-glycol (PEG-ADA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605719.RAEBrtS6W5-ZWvnZqF_Ey2QLXL9eg0yBczmyYLYKkPlHo130_provenance.